EBITDA Growth
15.64%
TTM · Period ending:
DBD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported15.64%period ending
Latest reported15.64%period ending
DBD TTM EBITDA YoY % (48.62% → 15.64%)
Year-over-year change
High-resolution chart · PNG
DBD ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -3.6943% | |
| 6.8383% | |
| 20.6655% | |
| 19.2393% | |
| 16.3218% | |
| 12.711% | |
| 11.9878% | |
| 10.1958% | |
| 3.5379% | |
| -4.4139% | |
| -7.6343% | |
| -1.203% | |
| 3.9346% | |
| 13.3405% | |
| 22.4466% | |
| 24.8436% | |
| 34.8725% | |
| 32.8806% | |
| 26.9597% | |
| 34.0604% | |
| 29.2075% | |
| 29.537% | |
| 29.3839% | |
| 14.7257% | |
| 5.3471% | |
| 15.508% | |
| 27.2618% | |
| 19.2882% | |
| 45.8276% | |
| 35.5072% | |
| 24.6617% | |
| 24.9641% | |
| 9.2676% | |
| 17.3469% | |
| 18.3274% | |
| 44.3064% | |
| 80.8108% | |
| 41.6867% | |
| 25.4464% | |
| 118.0696% | |
| 122.9102% | |
| 173.8434% | |
| -1.7544% | |
| -696.6518% | |
| -420.4365% | |
| -226.8623% | |
| 24.2507% | |
| -25.8278% | |
| -6.4935% | |
| -10.3239% | |
| -21.0753% | |
| -3.6683% | |
| 0.1859% | |
| 6.6955% | |
| -1.0638% | |
| 51.816% | |
| 48.6188% |